Pioneering prostate cancer research given a funding boost by the Hospital Saturday Fund.
Researchers at the University of Surrey who developed a revolutionary new urine test (called EN2) that can detect prostate cancer have been given a £10,000 grant to help fund their continuing work.
The money was presented to Professor Hardev Pandha, Head of Oncology at Surrey, by Paul Jackson, Chief Executive of the Hospital Saturday Fund charity, during a tour of the University’s research laboratories.
It will go towards funding the team’s continuing research, moving from the urine test to exploiting the fact that most common cancers make EN2 and display this protein on their surface. The team has developed prototype immune treatments targeting EN2 on cells (therefore highly selective for cancer). Early results suggest it may be possible to detect cancers making EN2 using antibodies labelled with fluorescent dyes using conventional imaging techniques. This will potentially allow doctors to monitor the size of tumours and the progress of patients after treatment.
Find out more on our Cancer research page.
Professor Pandha said: “It will cost approximately £660,000 over three years to progress this ground-breaking research, so we are very grateful to the Hospital Saturday Fund for their generous grant.”
With over 913,000 new cases recorded worldwide in 2008, prostate cancer is the second most common cause of cancer-related death in men.